Predicting the Future of Aesthetic Surgery: An Artificial Intelligence Framework for Global Publication Forecasting

Abstract

Abstract Background Artificial intelligence (AI) has transformed clinical decision making, yet its application to forecasting the evolution of surgical science remains underdeveloped. Anticipating future research trajectories represents a critical unmet need for strategic planning, workforce allocation, and innovation stewardship in aesthetic surgery. Objectives The aim of this study was to develop and validate an AI-assisted forecasting framework capable of modeling and predicting global aesthetic surgery research activity. Methods We performed a population-level observational analysis of all PubMed-indexed aesthetic surgery publications from 2010 to 2024. A fully autonomous AI pipeline conducted large-scale data ingestion, followed by high-fidelity semantic classification of publications by research domain and country (validated accuracy >97%). Annualized outputs were analyzed using optimized exponential-smoothing and autoregressive time-series models to generate long-horizon forecasts with 95% CIs. Results The framework processed 24,026 records, yielding 23,521 eligible publications across 13 journals. Exponential smoothing demonstrated superior predictive performance (R2 = 0.94, root mean square error = 166.6). Global research output is projected to increase by 21.9% by 2030, reaching 2939 publications annually (95% CI, 2612-3265). Minimally invasive and injectable research exhibited the steepest projected growth (+46.1 publications/year). Conclusions This study establishes AI-driven forecasting as a next-generation analytic paradigm for surgical meta-research. By integrating autonomous data ingestion, semantic intelligence, and rigorously validated time-series modeling, the framework operationalizes predictive intelligence—shifting aesthetic surgery research from retrospective surveillance to prospective trajectory mapping. The resulting system is scalable, reproducible, and continuously recalibratable, positioning AI as a strategic instrument for anticipatory research governance, resource allocation, and human-capital planning in surgical science. Level of Evidence: 5 (Therapeutic)

Ähnliche Arbeiten